Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study. | BMC Gastroenterol | 2023 | 37784019 | PubTator, text mining | PubMed |
| Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | 37779156 | PubTator, text mining | PubMed |
| Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer. | J Endocr Soc | 2023 | 37766843 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma. | BMC Complement Med Ther | 2023 | 37749558 | PubTator, text mining | PubMed |
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. | Cell Death Dis | 2023 | 37749143 | PubTator, text mining | PubMed |
| p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab. | Sci Rep | 2023 | 37749105 | PubTator, text mining | PubMed |
| The post-translational regulation of transcription factor EB (TFEB) in health and disease. | EMBO Rep | 2023 | 37728021 | PubTator, text mining | PubMed |
| mTOR signaling in hair follicle and hair diseases: recent progress. | Front Med (Lausanne) | 2023 | 37727765 | PubTator, text mining | PubMed |
| Regulation of phosphoglycerate kinase 1 and its critical role in cancer. | Cell Commun Signal | 2023 | 37723547 | PubTator, text mining | PubMed |
| Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson's Disease. | J Parkinsons Dis | 2023 | 37718851 | PubTator, text mining | PubMed |
| Continuous sensing of nutrients and growth factors by the mTORC1-TFEB axis. | Elife | 2023 | 37698461 | PubTator, text mining | PubMed |
| Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor. | Front Cardiovasc Med | 2023 | 37692050 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
| PI3K signaling through a biochemical systems lens. | J Biol Chem | 2023 | 37673340 | PubTator, text mining | PubMed |
| Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells. | Cell Death Discov | 2023 | 37669963 | PubTator, text mining | PubMed |
| New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics. | Front Oncol | 2023 | 37664036 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma. | Mol Cell Oncol | 2023 | 37649964 | PubTator, text mining | PubMed |
| Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes. | J Lipid Res | 2023 | 37640282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=7